| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
RAPT Therapeutics Inc (NASDAQ: RAPT)
RAPT Technical Analysis
4
| As on 9th Jun 2023 RAPT STOCK Price closed @ 20.54 and we RECOMMEND Sell for LONG-TERM with Stoploss of 21.95 & Strong Sell for SHORT-TERM with Stoploss of 25.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RAPTSTOCK Price
| Open | 21.30 | Change | Price | % |
| High | 21.30 | 1 Day | -0.63 | -2.98 |
| Low | 20.50 | 1 Week | 0.51 | 2.55 |
| Close | 20.54 | 1 Month | 2.46 | 13.61 |
| Volume | 191600 | 1 Year | -12.52 | -37.87 |
| 52 Week High 40.22 | 52 Week Low 10.26 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RAPT Daily Charts |
RAPT Intraday Charts |
Whats New @ Bazaartrend |
RAPT Free Analysis |
|
|
RAPT Important Levels Intraday
| RESISTANCE | 22.08 |
| RESISTANCE | 21.59 |
| RESISTANCE | 21.28 |
| RESISTANCE | 20.98 |
| SUPPORT | 20.10 |
| SUPPORT | 19.80 |
| SUPPORT | 19.49 |
| SUPPORT | 19.00 |
RAPT Forecast April 2024
| 4th UP Forecast | 63.03 |
| 3rd UP Forecast | 49.4 |
| 2nd UP Forecast | 40.98 |
| 1st UP Forecast | 32.56 |
| 1st DOWN Forecast | 8.52 |
| 2nd DOWN Forecast | 0.1 |
| 3rd DOWN Forecast | -8.32 |
| 4th DOWN Forecast | -21.95 |
RAPT Weekly Forecast
| 4th UP Forecast | 30.52 |
| 3rd UP Forecast | 27.32 |
| 2nd UP Forecast | 25.34 |
| 1st UP Forecast | 23.36 |
| 1st DOWN Forecast | 17.72 |
| 2nd DOWN Forecast | 15.74 |
| 3rd DOWN Forecast | 13.76 |
| 4th DOWN Forecast | 10.56 |
RAPT Forecast2024
| 4th UP Forecast | 80.05 |
| 3rd UP Forecast | 60.96 |
| 2nd UP Forecast | 49.17 |
| 1st UP Forecast | 37.37 |
| 1st DOWN Forecast | 3.71 |
| 2nd DOWN Forecast | -8.09 |
| 3rd DOWN Forecast | -19.88 |
| 4th DOWN Forecast | -38.97 |
RAPT Therapeutics Inc ( NASDAQ USA Symbol : RAPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RAPT Business Profile
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead oncology drug candidate is FLX475, an oral small molecule C-C motif chemokine receptor 4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company's lead inflammation drug candidate is RPT193 to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. It is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1 that are in the discovery stage of development. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Address: 561 Eccles Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service